
Adding oral L-glutamine to standard chemo nearly tripled median OS in advanced pancreatic cancer — and what comes next.

JunGong, MD, is associate professor of medicine and medical director of colorectal cancer at Cedars-Sinai.

Adding oral L-glutamine to standard chemo nearly tripled median OS in advanced pancreatic cancer — and what comes next.